Literature DB >> 24842524

Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT.

A Xhaard1, H Moins-Teisserenc2, M Busson3, M Robin1, P Ribaud1, N Dhedin1, S Abbes1, M Carmagnat4, V-D Kheav5, G Maki4, R Peffault de Latour1, A Toubert2, G Socié6.   

Abstract

Previous studies on regulatory T-cell (Treg) reconstitution after allogeneic hematopoietic SCT (HSCT) have suggested that, within the GVHD process, imbalance between effector T cells and Tregs may be more important than the absolute numbers of circulating Tregs. No study has analyzed naive vs memory Treg reconstitution in a longitudinal cohort with large numbers of patients. The reconstitution of total and subsets of Treg was prospectively analyzed by flow cytometry in 185 consecutive recipients at 3, 6, 12 and 24 months after allogeneic HSCT. The levels of total, naive and memory Tregs increased, mainly within the memory subset, but remained lower than healthy controls up to 2 years after transplantation. Reduced-intensity conditioning and peripheral blood (PBSC) as the source of stem cells were associated with better 3-month reconstitution. In multivariate analysis, PBSC, recipient age ⩽25 and no anti-thymoglobulin in the conditioning regimen were associated with a better Treg reconstitution. Naive Treg long-term reconstitution was mainly influenced by recipient age. Whereas prior acute GVHD impaired Treg reconstitution, Treg subsets (absolute numbers and frequencies relative to CD4(+) T-cell subsets) at 3, 6 and 12 months after HSCT were not associated with the occurrence of a later episode of chronic GVHD.

Entities:  

Mesh:

Year:  2014        PMID: 24842524     DOI: 10.1038/bmt.2014.105

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  14 in total

1.  Reconstitution of maturating and regulatory lymphocyte subsets after cord blood and BMT in children.

Authors:  E Charrier; P Cordeiro; R-M Brito; S Mezziani; S Herblot; F Le Deist; M Duval
Journal:  Bone Marrow Transplant       Date:  2012-10-15       Impact factor: 5.483

2.  Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.

Authors:  Ken-ichi Matsuoka; Haesook T Kim; Sean McDonough; Gregory Bascug; Ben Warshauer; John Koreth; Corey Cutler; Vincent T Ho; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Jerome Ritz
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

3.  Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.

Authors:  Caron A Jacobson; Amin T Turki; Sean M McDonough; Kristen E Stevenson; Haesook T Kim; Grace Kao; Maria I Herrera; Carol G Reynolds; Edwin P Alyea; Vincent T Ho; John Koreth; Philippe Armand; Yi-Bin Chen; Karen Ballen; Robert J Soiffer; Joseph H Antin; Corey S Cutler; Jerome Ritz
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-26       Impact factor: 5.742

4.  Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells.

Authors:  Sya N Ukena; Jens Grosse; Eva Mischak-Weissinger; Stefanie Buchholz; Michael Stadler; Arnold Ganser; Anke Franzke
Journal:  Ann Hematol       Date:  2010-09-22       Impact factor: 3.673

5.  Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

Authors:  Claudio G Brunstein; Jeffrey S Miller; Qing Cao; David H McKenna; Keli L Hippen; Julie Curtsinger; Todd Defor; Bruce L Levine; Carl H June; Pablo Rubinstein; Philip B McGlave; Bruce R Blazar; John E Wagner
Journal:  Blood       Date:  2010-10-15       Impact factor: 22.113

6.  Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.

Authors:  Junya Kanda; Lun-Wei Chiou; Paul Szabolcs; Gregory D Sempowski; David A Rizzieri; Gwynn D Long; Keith M Sullivan; Cristina Gasparetto; John P Chute; Ashley Morris; Jacalyn McPherson; Jeffrey Hale; John Andrew Livingston; Gloria Broadwater; Donna Niedzwiecki; Nelson J Chao; Mitchell E Horwitz
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-12       Impact factor: 5.742

7.  Long-term immune deficiency after allogeneic stem cell transplantation: B-cell deficiency is associated with late infections.

Authors:  Elise Corre; Maryvonnick Carmagnat; Marc Busson; Regis Peffault de Latour; Marie Robin; Patricia Ribaud; Antoine Toubert; Claire Rabian; Gerard Socié
Journal:  Haematologica       Date:  2010-02-04       Impact factor: 9.941

8.  CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.

Authors:  Matthias Edinger; Petra Hoffmann; Joerg Ermann; Kathryn Drago; C Garrison Fathman; Samuel Strober; Robert S Negrin
Journal:  Nat Med       Date:  2003-08-17       Impact factor: 53.440

9.  Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.

Authors:  Makoto Miyara; Yumiko Yoshioka; Akihiko Kitoh; Tomoko Shima; Kajsa Wing; Akira Niwa; Christophe Parizot; Cécile Taflin; Toshio Heike; Dominique Valeyre; Alexis Mathian; Tatsutoshi Nakahata; Tomoyuki Yamaguchi; Takashi Nomura; Masahiro Ono; Zahir Amoura; Guy Gorochov; Shimon Sakaguchi
Journal:  Immunity       Date:  2009-05-21       Impact factor: 31.745

10.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  13 in total

1.  Immune reconstitution in patients with acquired severe aplastic anemia after haploidentical stem cell transplantation.

Authors:  X-Y Pei; X-Y Zhao; L-P Xu; Y Wang; X-H Zhang; Y-J Chang; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2017-08-14       Impact factor: 5.483

2.  HTLV-I-associated posttransplant lymphoproliferative disorder following virus transmission from recipient to donor cells.

Authors:  Noriaki Kitamura; Tsukasa Nakanishi; Yasuhiro Yoshida; Takehiro Higashi; Junichi Tsukada
Journal:  Blood       Date:  2017-05-09       Impact factor: 22.113

3.  Reconstitution and clinical significance of T cell subsets in the early stage after related HLA-mismatched peripheral blood hematopoietic SCT without T-cell depletion in vitro.

Authors:  Nannan Pang; Xianlin Duan; Ming Jiang; Jianhua Qu; Hailong Yuan; Jianli Xu; Haizhou Cao; Gang Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 4.  Immune-Mediated Cytopenias After Hematopoietic Cell Transplantation: Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment Strategies.

Authors:  Thomas F Michniacki; Christen L Ebens; Sung Won Choi
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

5.  Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT.

Authors:  M Murata; K Ikegame; Y Morishita; H Ogawa; K Kaida; H Nakamae; T Ikeda; T Nishida; M Inoue; T Eto; K Kubo; T Sakura; T Mori; N Uchida; T Ashida; Y Matsuhashi; Y Miyazaki; T Ichinohe; Y Atsuta; T Teshima
Journal:  Bone Marrow Transplant       Date:  2016-11-21       Impact factor: 5.483

Review 6.  Mechanistic approaches for the prevention and treatment of chronic GVHD.

Authors:  Corey S Cutler; John Koreth; Jerome Ritz
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

7.  Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD.

Authors:  Ana C Alho; Haesook T Kim; Marie J Chammas; Carol G Reynolds; Tiago R Matos; Edouard Forcade; Jennifer Whangbo; Sarah Nikiforow; Corey S Cutler; John Koreth; Vincent T Ho; Philippe Armand; Joseph H Antin; Edwin P Alyea; Joao F Lacerda; Robert J Soiffer; Jerome Ritz
Journal:  Blood       Date:  2015-12-15       Impact factor: 22.113

8.  High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation.

Authors:  Caroline Ritacco; Grégory Ehx; Céline Grégoire; Coline Daulne; Evelyne Willems; Sophie Servais; Yves Beguin; Frédéric Baron
Journal:  Bone Marrow Transplant       Date:  2021-03-04       Impact factor: 5.174

9.  Tolerogenic anti-IL-2 mAb prevents graft-versus-host disease while preserving strong graft-versus-leukemia activity.

Authors:  Qingxiao Song; Xiaoning Wang; Xiwei Wu; Hanjun Qin; Yingfei Li; Arthur D Riggs; Paul J Martin; Yuan-Zhong Chen; Defu Zeng
Journal:  Blood       Date:  2021-04-22       Impact factor: 25.476

10.  Rapid reconstitution of regulatory T-cell subsets is associated with reduced rates of acute graft-versus-host disease and absence of viremia after cord blood transplantation in children with reduced-intensity conditioning using alemtuzumab.

Authors:  Xiaohua Chen; Memphis Hill; Mark Vander Lugt; Maria Escolar; Zhou Fang; Wei Chen; Paul Szabolcs
Journal:  Cytotherapy       Date:  2020-02-21       Impact factor: 6.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.